Oxy 3 in 1 Acne Pads

Description

Oxy 3 in 1 Acne Pads are formulated for the treatment of acne. Each pad contains active ingredients designed to target acne-causing bacteria, reduce inflammation, and promote clearer skin. The product is presented in a convenient pad dosage form, allowing for easy application. The pads are designed to be used as part of a comprehensive acne treatment regimen.

Uses and Indications

This drug is indicated for the treatment and prevention of acne.

There are no teratogenic effects associated with this medication. Additionally, no nonteratogenic effects have been reported.

Dosage and Administration

The affected area should be cleansed and covered with a thin layer of the medication using a pad. The recommended frequency of application is 1 to 3 times daily. It is advisable to initiate treatment with a single application per day, gradually increasing to 2 or 3 times daily as necessary or as directed by a healthcare professional.

In cases where bothersome dryness or peeling occurs, the frequency of application should be reduced to once daily or every other day.

Prior to full application, a sensitivity test is recommended. This involves applying the product sparingly to a small affected area for the first 3 days. If no discomfort is experienced during this period, the patient may proceed with the standard application regimen as outlined above.

Contraindications

Use of this product is contraindicated in situations where the pad may be left on the skin. Prolonged contact with the skin could lead to irritation or other adverse effects. No other specific contraindications have been identified.

Warnings and Precautions

For external use only. It is imperative to avoid contact with the eyes, lips, and mouth. In the event of accidental contact, the affected area should be flushed thoroughly with water to mitigate any potential irritation.

The concurrent use of this product with other topical acne medications may increase the likelihood of skin irritation and dryness. To minimize the risk of adverse effects, it is recommended that only one topical acne medication be used at a time. Additionally, the product should not be left on the skin for extended periods.

In cases of accidental ingestion, immediate medical assistance should be sought, or the individual should contact a Poison Control Center without delay.

For individuals who are pregnant or breastfeeding, it is advisable to consult a healthcare professional prior to use to ensure safety for both the mother and child.

Side Effects

Patients using this product should be aware that it is for external use only. Care should be taken to avoid contact with the eyes, lips, and mouth; in the event of contact, the affected area should be flushed thoroughly with water.

Skin irritation and dryness are common adverse reactions, particularly if the product is used concurrently with another topical acne medication. To minimize the risk of irritation, it is advised that patients use only one topical acne medication at a time. Additionally, patients should not leave the pad on the skin for extended periods.

In the event of accidental ingestion, it is crucial to seek medical assistance or contact a Poison Control Center immediately. This product should be kept out of reach of children to prevent any potential harm.

Drug Interactions

Concurrent use of topical acne medications may increase the risk of skin irritation and dryness. It is advisable to limit the use to one topical acne medication at a time to minimize the potential for adverse effects. If irritation occurs, the patient should discontinue the use of additional topical agents and consult a healthcare professional for further guidance.

Packaging & NDC

Below are the non-prescription pack sizes of Oxy 3 in 1 Acne Pads (salicylic acid). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be advised to keep this medication out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought, or contact with a Poison Control Center is recommended.

Geriatric Use

There is no specific information regarding the use of OXY 3 IN 1 ACNE PADS in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when recommending this product to elderly patients, as the absence of data necessitates careful consideration of individual patient factors and potential sensitivities. Monitoring for any adverse reactions or changes in skin condition is advisable when this product is used in the geriatric population.

Pregnancy

Pregnant patients and those who are breastfeeding should consult a healthcare professional prior to using this medication. The safety of this drug during pregnancy has not been established, and potential risks to fetal outcomes are not fully understood. Therefore, it is essential for women of childbearing potential to seek medical advice to weigh the benefits and risks associated with the use of this medication during pregnancy and lactation.

Lactation

Lactating mothers are advised to consult a health professional prior to using this medication. There is no specific data available regarding the excretion of this medication in breast milk or its effects on breastfed infants. Therefore, caution is recommended when administering this medication to lactating individuals.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available prescribing information. There are no dosage adjustments, special monitoring requirements, or safety considerations outlined for individuals with reduced kidney function. Healthcare professionals should exercise caution and consider the lack of data when prescribing to this patient population.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in clinical trials for this medication. Consequently, there is no available information regarding dosage adjustments, special monitoring requirements, or precautions for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be warranted based on clinical judgment.

Overdosage

In the event of an overdosage, immediate medical assistance is crucial. If the substance is ingested, healthcare professionals should advise patients or caregivers to seek medical help or contact a Poison Control Center without delay.

Prompt intervention is essential to mitigate potential adverse effects associated with overdosage. Symptoms may vary depending on the specific substance involved, and healthcare providers should be prepared to assess and manage these symptoms accordingly.

Management procedures may include supportive care and symptomatic treatment, tailored to the individual patient's needs. Continuous monitoring and evaluation are recommended to ensure patient safety and effective resolution of any complications arising from the overdosage.

Nonclinical Toxicology

If pregnant or breastfeeding, it is advised to consult a health professional prior to use.

Skin irritation and dryness may be exacerbated when used concurrently with other topical acne medications. In cases of irritation, it is recommended to limit the use to one topical acne medication at a time.

No relevant information is available regarding carcinogenicity, mutagenicity, or impairment of fertility. Additionally, there is no pertinent data from animal pharmacology and toxicology studies.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to keep the medication out of reach of children to prevent accidental ingestion. Instruct patients that if the product is swallowed, they should seek medical help or contact a Poison Control Center immediately.

Patients should be informed to avoid contact with the eyes, lips, and mouth. In the event of contact, they should flush the area thoroughly with water. It is important to discuss the potential for skin irritation and dryness, particularly if patients are using another topical acne medication concurrently. Patients should be counseled to use only one topical acne medication at a time to minimize the risk of irritation.

Additionally, healthcare providers should emphasize that patients should not leave the pad on the skin for extended periods. Finally, patients who are pregnant or breastfeeding should be encouraged to consult a health professional before using the product to ensure safety.

Storage and Handling

The product is supplied in a tightly sealed container to ensure its integrity. It is essential to avoid storing the product at temperatures exceeding 100°F (38°C) and to protect it from freezing conditions. Additionally, the product should be kept away from sources of flame, fire, and heat to maintain its quality and safety.

Additional Clinical Information

The medication is administered topically, with patients instructed to cleanse the affected area and apply a thin layer of the medicine using a pad 1 to 3 times daily. Initial application should start with once daily, gradually increasing to 2 or 3 times daily as needed or directed by a healthcare provider. If patients experience bothersome dryness or peeling, they should reduce the frequency to once a day or every other day.

Clinicians should counsel patients that the product is for external use only and must be kept away from the eyes, lips, and mouth; in case of contact, thorough flushing with water is recommended. Concurrent use of other topical acne medications may increase the risk of skin irritation and dryness, so it is advised to use only one topical acne treatment at a time. Patients should not leave the pad on the skin, and those who are pregnant or breastfeeding should consult a healthcare professional before use. The medication should be kept out of reach of children, and in the event of ingestion, medical assistance or contact with a Poison Control Center is necessary.

Drug Information (PDF)

This file contains official product information for Oxy 3 in 1 Acne Pads, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)